BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 28157706)

  • 1. Sphingolipid metabolism in colorectal adenomas varies depending on histological architecture of polyps and grade of nuclear dysplasia.
    Kurek K; Łukaszuk B; Świdnicka-Siergiejko A; Rogalski P; Wróblewski E; Chabowski A; Dąbrowski A; Żendzian-Piotrowska M
    Lipids; 2015 Apr; 50(4):349-58. PubMed ID: 25595595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of LINE-1 Hypomethylation With Size and Pathologic Extent of Dysplasia in Colorectal Tubular Adenomas.
    Jiang AC; Buckingham L; Bishehsari F; Sutherland S; Ma K; Melson JE
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00369. PubMed ID: 34060495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium is associated with colorectal adenomas.
    McCoy AN; Araújo-Pérez F; Azcárate-Peril A; Yeh JJ; Sandler RS; Keku TO
    PLoS One; 2013; 8(1):e53653. PubMed ID: 23335968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shorter peripheral blood telomeres are a potential biomarker for patients with advanced colorectal adenomas.
    Riegert-Johnson DL; Boardman LA; Crook JE; Thomas CS; Johnson RA; Roberts ME
    Int J Biol Markers; 2012 Dec; 27(4):e375-80. PubMed ID: 22865299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early screening of colorectal cancer using feature engineering with artificial intelligence-enhanced analysis of nanoscale chromatin modifications.
    Chang A; Prabhala S; Daneshkhah A; Lin J; Subramanian H; Roy HK; Backman V
    Sci Rep; 2024 Apr; 14(1):7808. PubMed ID: 38565871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early screening of colorectal cancer using feature engineering with artificial intelligence-enhanced analysis of nanoscale chromatin modifications.
    Chang A; Prabhala S; Daneshkhah A; Lin J; Subramanian H; Roy HK; Backman V
    Res Sq; 2023 Oct; ():. PubMed ID: 37961494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early screening of colorectal cancer using feature engineering with artificial intelligence-enhanced analysis of nanoscale chromatin modifications.
    Chang A; Prabhala S; Daneshkhah A; Lin J; Subramanian H; Roy HK; Backman V
    medRxiv; 2023 Oct; ():. PubMed ID: 37961299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of adipokine ghrelin and ghrelin receptor in human colorectal adenoma and correlation with the grade of dysplasia.
    Stojsavljevic-Shapeski S; Virovic-Jukic L; Tomas D; Duvnjak M; Tomasic V; Hrabar D; Kralj D; Budimir I; Barsic N; Ljubicic N
    World J Gastrointest Surg; 2021 Dec; 13(12):1708-1720. PubMed ID: 35070075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tribbles Pseudokinases in Colorectal Cancer.
    Ferreira BI; Santos B; Link W; De Sousa-Coelho AL
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34198908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of a novel EGFR specific immunotoxin and its efficacy of anti-colorectal cancer in vitro and in vivo.
    Wu S; Deng C; Zhang C; Xiong J; Gu X; Wang Z; Tu J; Xie J
    Clin Transl Oncol; 2021 Aug; 23(8):1549-1560. PubMed ID: 33474678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity.
    Morgan RG; Mortensson E; Legge DN; Gupta B; Collard TJ; Greenhough A; Williams AC
    Br J Cancer; 2018 Feb; 118(4):558-565. PubMed ID: 29149105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions.
    Halliday G; Porter RJ; Black CJ; Arends MJ; Din S
    World J Gastroenterol; 2022 Apr; 28(13):1338-1346. PubMed ID: 35645542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.
    Chen YT; Tsao SC; Yuan SS; Tsai HP; Chai CY
    Pathol Oncol Res; 2015 Sep; 21(4):1201-8. PubMed ID: 26037168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas.
    Porebska I; Harlozińska A; Bojarowski T
    Tumour Biol; 2000; 21(2):105-15. PubMed ID: 10686540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubular adenomas with clear cell change in the colorectum: A case with four lesions and a review of the literature.
    Miyasaka C; Ishida M; Ohe C; Uemura Y; Ando Y; Fukui T; Tsuta K
    Pathol Int; 2018 Apr; 68(4):256-258. PubMed ID: 29330907
    [No Abstract]   [Full Text] [Related]  

  • 16. The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker.
    Williet N; Petcu CA; Rinaldi L; Cottier M; Del Tedesco E; Clavel L; Dumas O; Jarlot C; Bouarioua N; Roblin X; Peoc'h M; Phelip JM
    Oncotarget; 2017 Mar; 8(10):16507-16517. PubMed ID: 28157706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: a pilot correlative case series.
    Bansal A; Liu X; McGregor DH; Singh V; Hall S
    Am J Med Sci; 2010 Oct; 340(4):296-300. PubMed ID: 20622650
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.